Last reviewed · How we verify

sevoflurane and fentanil

Hospital de Base · FDA-approved active Small molecule Quality 5/100

sevoflurane and fentanil is a Small molecule drug developed by Hospital de Base. It is currently FDA-approved. Also known as: Standard general anesthesia.

At a glance

Generic namesevoflurane and fentanil
Also known asStandard general anesthesia
SponsorHospital de Base
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about sevoflurane and fentanil

What is sevoflurane and fentanil?

sevoflurane and fentanil is a Small molecule drug developed by Hospital de Base.

Who makes sevoflurane and fentanil?

sevoflurane and fentanil is developed and marketed by Hospital de Base (see full Hospital de Base pipeline at /company/hospital-de-base).

Is sevoflurane and fentanil also known as anything else?

sevoflurane and fentanil is also known as Standard general anesthesia.

What development phase is sevoflurane and fentanil in?

sevoflurane and fentanil is FDA-approved (marketed).

Related